MedPath

Effect of High Flow Nasal During Exercise in COPD Patients

Not Applicable
Completed
Conditions
COPD Exacerbation
Interventions
Device: High Flow nasal cannula
Registration Number
NCT03058081
Lead Sponsor
Groupe Hospitalier du Havre
Brief Summary

Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. High flow ventilation in reducing work of breathing and dyspnea may improve exercise tolerance. The aim of this study is to carry out the acute effect of high flow nasal cannula on exercise endurance in post-exacerbation copd patients

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • a diagnosis of COPD
Exclusion Criteria
  • exercise contraindication Any musculoskeletal problems, cardiovascular or neurological comorbidities that limits exercise.
  • pH < 7,35
  • Body temperature > 38°C
  • cardiac frequency > 100 bpm at rest
  • systolic blood pressure < 100 mmHg
  • exacerbation during the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
High Flow Nasal TestHigh Flow nasal cannulaPatients will perform one Constant Work-Rate Exercise Test at 80% of maximum workload with High Flow Nasal at 60L/min (with or without additional oxygen)
Primary Outcome Measures
NameTimeMethod
Difference in exercise capacityThe outcome will be measure after every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum

Difference in endurance time (TLim) during High Intensity Constant Work-Rate Endurence Test (CWRET)

Secondary Outcome Measures
NameTimeMethod
Difference in peripheral muscle oxygenationThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exercise

Muscle oxygenation will be evaluated using Near-infrared spectroscopy technology.

Difference in Cardiac FrequencyThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exercise

Difference in Cardiac Frequence using a pulse oximetry

Difference in Dyspnea and muscular fatigueThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be collected every 2 minute during tests and at the end of the exercise

Difference in dyspnea and muscular fatigue using Modified Borg Scale (0 - 10 points)

Difference in Respiratory Muscle FatigueThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be collected before and 5 minute maximum after exercise

Difference in Respiratory Muscle Fatigue using an electronical manometer

Difference in Oxygen SaturationThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exercise

Difference in Oxygen Saturation using a pulse oximetry (SpO2)

Difference in Transcutaneous Carbon DioxideThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exercise

Difference Transcutaneous Carbon Dioxide using Transcutaneous Carbon Dioxide using a Transcutaneous capnography

Difference in Respiratory RateThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exercise

Difference in Respiratory Rate using a Respiratory Inductive Plethysmography

Trial Locations

Locations (1)

Groupe Hospitalier du Havre

🇫🇷

Montivilliers, France

© Copyright 2025. All Rights Reserved by MedPath